Regeneron receives FDA approval for EYLEA HD
diabetic macular edema

Regeneron receives FDA approval for EYLEA HD

The Food and Drug Administraton (FDA) gave approval after two active-controlled, double-masked pivotal trials, which compared EYLEA HD to EYLEA over a 48 week period.
New type of eye drop may help treat retinal diseases
diabetic macular edema

New type of eye drop may help treat retinal diseases

For patients suffering from blinding retinal diseases like diabetic macular edema, the only treatment options they currently have are surgery or injections.
Experimental drug shows promise in preventing diabetic retinal vascular diseases
diabetic macular edema

Experimental drug shows promise in preventing diabetic retinal vascular diseases

An experimental drug that had previously demonstrated an ability to slow the growth of liver tumors in mice, has now shown an ability to prevent diabetic retinal vascular disease.